Patient's question:
Please ask, if a newborn with sepsis complicated with encephalitis is actively treated, will it have an impact on the child's brain in the future, and will it lead to dementia?Doctor's answer:
Hello;Treatment Measures
1. Antibiotics
Neonatal sepsis requires antibiotic treatment before blood culture results are available, followed by selection of antibiotics based on blood culture results and bacterial susceptibility tests. Typically, a combination of one penicillin-class and one aminoglycoside-class antibiotic is used as the initial treatment due to their broad antimicrobial spectrum and synergistic effects. In severe cases of infection, third-generation cephalosporins combined with penicillin-class antibiotics may be used.
(1) Escherichia coli sepsis
It is generally believed that E. coli infection is predominant in cases of premature rupture of membranes, prolonged labor, intrapartum infection, and onset within the first 3 days after birth. Amoxicillin combined with gentamicin or tobramycin can be used. Amoxicillin is a commonly used antibiotic for bacterial infections in newborns, exhibiting strong antibacterial activity against both cocci and common pathogens such as E. coli and Haemophilus influenzae.
Dosage:
- ≤7 days of age: 50 mg/(kg·d) administered via intravenous infusion twice daily;
- >7 days of age: 75 mg/(kg·d) administered via intravenous injection three times daily.
Gentamicin dosage:
- <1500 g: 3 mg/(kg·d), administered once daily;
- 1500–2500 g: 3 mg/(kg·d), administered twice daily;
- >2500 g: 5 mg/(kg·d), administered every 8 hours.
Due to the ototoxic side effects of gentamicin, blood drug concentration monitoring should be performed during use. Since the susceptibility of E. coli strains varies widely, antibiotics should be selected based on susceptibility tests combined with clinical judgment. If resistance to these antibiotics or poor clinical efficacy is observed, third-generation cephalosporins can be used. Third-generation cephalosporins are effective in treating sepsis caused by aerobic Gram-negative and Gram-positive bacteria, with particularly outstanding efficacy against Gram-negative bacteria, achieving an effective rate of 84%–97%. For example, cefotaxime and ceftriaxone not only have significant bactericidal effects but can also penetrate an inflamed blood-brain barrier.
Dosage for these two cephalosporins:
- Cefotaxime:
- ≤7 days of age: 100 mg/(kg·d), administered via intravenous injection twice daily;
- >7 days of age: 150 mg/(kg·d), administered via intravenous injection three times daily.
- Ceftriaxone: 50 mg/(kg·d), administered once or twice daily via intravenous injection.
The treatment course is approximately 2–3 weeks.
(2) Staphylococcus aureus sepsis
Newborns with purulent infections of the skin or mucosa, as well as those born in hospitals and hospitalized for extended periods, are often infected with S. aureus. Treatment can involve penicillin, but most S. aureus strains are resistant to penicillin, so acid-resistant penicillins such as oxacillin, cloxacillin, or nafcillin are commonly used, or vancomycin combined with the aforementioned acid-resistant penicillins.
Dosage for these three acid-resistant penicillins:
- <2000 g:
- ≤7 days of age: 50 mg/(kg·d), administered twice daily;
- >7 days of age: 100 mg/(kg·d), administered three times daily;
- >2000 g:
- ≤7 days of age: 75 mg/(kg·d), administered three times daily;
- >7 days of age: 150 mg/(kg·d), administered four times daily;
All are administered via intravenous route.
Vancomycin dosage:
- Preterm infants with gestational age <37 weeks: 15 mg/kg, administered every 12 hours;
- Full-term infants: 10–15 mg/kg, administered every 8 hours;
All are administered via intravenous route.
The treatment course is 7–10 days. Alternatively, second-generation cephalosporins such as cefuroxime can be used at a dosage of 50–100 mg/(kg·d), administered twice daily via intravenous injection.
(3) Streptococcal sepsis
Group B streptococcal (GBS) sepsis has early clinical manifestations similar to neonatal respiratory distress syndrome, making differentiation difficult. High-dose penicillin (200,000–400,000 U/(kg·d)) should be administered via intravenous injection 2–3 times daily.
(4) Anaerobic sepsis
In recent years, neonatal anaerobic infections have been gradually increasing, commonly occurring in cases of premature rupture of membranes and postoperative complications. Metronidazole (Flagyl) is the first-line treatment.
Dosage:
- ≤7 days of age: 15 mg/(kg·d), administered twice daily via intravenous injection;
- >7 days of age: 30 mg/(kg·d), administered 2–3 times daily via intravenous injection.
The treatment course is 7–10 days.
(5) Hospital-acquired sepsis caused by intrauterine infection
Hospital-acquired infections are easily contracted after hospitalization, especially with invasive treatments (e.g., umbilical vein catheterization, tracheal intubation) and prolonged use of broad-spectrum antibiotics, as well as in crowded wards. For sepsis caused by coagulase-negative staphylococci, vancomycin should be used at the aforementioned dosage, with a treatment course of 7–10 days. For sepsis caused by Gram-positive bacteria, aminoglycoside-class antibiotics such as gentamicin should be used at the aforementioned dosage. However, due to the high prevalence of gentamicin resistance, tobramycin, which has lower resistance rates, is often preferred.
Tobramycin dosage:
- <1500 g: 10 mg/(kg·d), administered once daily via intravenous injection;
- 1500–2500 g: 10 mg/(kg·d), administered twice daily via intravenous injection;
- >2500 g: 20 mg/(kg·d), administered twice daily via intravenous injection.
Since aminoglycoside-class antibiotics have common side effects such as ototoxicity and nephrotoxicity, serum drug concentration monitoring is necessary.
2. General treatment
Maintain warmth, ensure water and electrolyte balance, and supplement calories. Correct acidosis and hypoxia promptly, and manage local infection foci such as the umbilicus and skin.
3. Symptomatic treatment
Use anticonvulsants for seizures, phototherapy for jaundice, and reduce intracranial pressure promptly for cerebral edema.
4. Supportive treatment
Administer blood or plasma in small, frequent doses to enhance the body's resistance.
5. Immunotherapy
Neonatal immune systems are underdeveloped, especially in low-birth-weight infants, making them less responsive to various antigens after birth. Infections further weaken their immunity. Therefore, immunotherapy can improve neonatal immunity and enhance anti-infection capabilities.